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Introduction
Insulin exerts a large series of integrated actions via
a receptor-mediated intracellular signaling system.1
The insulin receptor,a member of the tyrosine kinase
growth  factor  receptor  family, is  phosphorylated
upon insulin binding; then, it induces the phospho-
rylation of multiple tyrosine residues within the C-
terminus of a family of signaling molecules referred
to as insulin receptor substrate (IRS) proteins,2–4 the
best  characterized of  which  are  IRS-1 and IRS-2.
The anchoring of IRS-1 and IRS-2 to the detergent-
resistant  insoluble  fraction  corresponding  to  the
cytoskeleton5–8 facilitates  interaction  with  down-
stream  signaling  proteins. The  advantage  of  this
signaling system is that, since tyrosine phosphoryla-
tion of IRS is catalytic, IRS proteins provide a means
for signal ampli￿ cation by eliminating the need for
stoichiometric ratios of receptors that directly recruit
SH2-containing proteins to their auto-phosphoryla-
tion sites.
Do IRS-1 and IRS-2 serve the same cellular func-
tions? The  similar  tissue  distribution  may  suggest
signalling redundancy; however, a number of differ-
ences  have  been  documented: mice  with  targeted
disruption of IRS-1 and -2 are beginning to reveal
functional  differences. In contrast  to  mice  lacking
IRS-1  that  look  normal,9 IRS-2  knockout  mice
develop overt diabetes.10 IRS-1 appears to have its
major role in muscle,whereas IRS-2 mediates insulin
action in liver, fat, and muscle.11,12 Knockout mice
have shown that disruption of IRS- gene results in
compensatory mechanisms affecting the function of
the  other  substrates.13 Furthermore, while  insulin
can stimulate IRS-1-associated Grb-2 phosphoryla-
tion  as  well  as  tyrosine  phosphorylation  of  Shc
proteins, nearly  no  Grb-2  phosphorylation  was
detected when IRS-2 was analyzed in fetal rat brown
adipocytes.14 Another differential response is related
to the ￿ nding that IRS-1 displays a more sustained
signal than IRS-2.5
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Abstract
Purpose: Insulin receptor substrates (IRSs) are essential for insulin-induced mitogenic effects on several cell types but they
also are involved in cell transformation.We investigated whether the differential constitutive expression and potential distinct
downstream signaling events of IRS-1 and IRS-2 might be related to discrete tumourigenic phenotypes of three human
uterine leiomyosarcoma cell lines, one of which was speci￿ cally isolated for the present study.
Methods and results: SK-UT-1B egressed effectively from a gelly￿ ed Matrigel matrix and grew as did DMR cells in an
anchorage-independent manner in agar and induced rapidly growing tumours in nude mice. On the contrary, SK-LMS-1
cells did not emigrate from Matrigel, neither grew in agar nor were they tumourigenic. IRS-2 was highly expressed in the
more malignant cell lines, whereas IRS-1 was present only in SK-LMS-1 cells.However,upon insulin stimulation both IRS-
1 and IRS-2 were tyrosine phosphorylated with a similar kinetic in the respective cell lines; furthermore, after 1 min of
insulin stimulation PI3-kinase associated with IRSs and after 2 min Shc was phosphorylated and associated with Grb2 with
minor differences detectable among the various cell lines in the duration of phosphorylation and/or in their association irre-
spective of whether IRS-1 or IRS-2 were expressed.
Discussion: Our ￿ ndings tend to exclude that the malignancy displayed by uterine leiomyosarcomas might be directly linked
to the activation of distinct IRS-1- or IRS-2-dependent pathways.
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DOI: 10.1080/1357714021000065387Leiomyosarcomas in soft tissue are relatively rare
neoplasms. They show a wide range of behaviours,
i.e., nearly  benign  to  severely  malignant. Uterine
leiomyosarcomas  are  aggressive  tumours  with  a
recurrence rate  of  71%,15 with  tumour size  being
found as a major prognostic parameter only in one
study.16 Few  studies  have  focused  on  their
biology,17,18 and  prognostic  factors  are  currently
sought  with  the  aim  of  recognizing  predictors  of
patient survival.We investigated the possible involve-
ment of IRS-1 and IRS-2 in the determination of the
malignant  phenotype  of  three  uterine  leiomyosar-
coma cell lines.
Materials and methods
Antibodies
Rabbit  polyclonal  antibodies  to  Shc  and  mouse
monoclonal  antibodies  to  Grb-2  were  purchased
from  Transduction  Laboratories  (Lexington, KY,
USA). Anti-phosphotyrosine  monoclonal  antibody
(PY20), rabbit polyclonal antibodies to IRS-1, IRS-
2 and PI3-K, and goat polyclonal HRP-conjugated
antibodies to rabbit or mouse IgG H+L were from
Upstate Biotechnology (Lake Placid, NY, USA).
Cell lines
The uterine leiomyosarcoma cell lines SK-LMS-119
and SK-UT-1B20 were purchased from ATCC.DMR
cells  were  isolated  from  the  buffy  coat  from  the
peripheral blood of a patient with a relapsed uterine
leiomyosarcoma referred to our Institution in May
1997.Within 8–10 days of culture from the ‘spongy’
clot at the bottom of the ￿ ask, adherent transformed
cells started growing and were then trasferred twice
a week.During the course of these studies DMR cells
were used at passage 35 or above; a more complete
description  of  the  isolation  procedures  and  other
properties of this cell line will be presented in a sepa-
rate report. SK-LMS-1, SK-UT-1B and DMR were
maintained in DMEM supplemented with 10% FCS
(Gibco, Paisley, UK), 2 mM glutamine, 100  U/ml
penicillin, 500 m g/ml gentamicin, 100 m g/ml strep-
tamicin (Sigma, St. Louis, MO, USA). Cells were
cultured at 37°C with 5% CO2.
Anchorage-independent growth assay
To assay the ability of single cells to proliferate while
suspended in a semisolid medium, a soft agar assay
was used. Cells (7.5 ´ 104 and 3.75 ´ 104 cells/well)
were seeded in 1 ml complete medium containing
0.3%  agarose Type VII  Low  Gelling Temperature
(Sigma)  on  top  of  a  solid  underlay  of  2  ml 
0.5% agarose in complete medium. Six-well plates
were  incubated  at  37°C  with  5%  CO2 for  up  to 
10  days  and  the  number  of  colonies  determined
macroscopically.
Effect of Matrigel on in vitro invasion
Matrigel, an  extract  of  the  murine  Engelbreth-
Holm-Swarm  (EHS)  tumour  grown  in  C57/Bl6
mice, was from Collaborative Biochemical Products
(Becton-Dickinson  Labware, Bedford, MA). Sub-
con￿ uent cultures were washed with PBS, harvested
with trypsin,centrifuged and the pellet (5 ´ 103 cells)
was resuspended in 10 m l Matrigel (10 m g/ml, kept at
4°C).The droplets were plated in a six-well plate and
the mixtures were incubated at 37°C for 30 min to
allow for polymerization. Then DMEM containing
10% FCS was added and the ability of the cells to
egress from Matrigel was evaluated taking images at
24 h on a Leica DM IRB inverted microscope (Leica
Microsystems Wetzlar GmbH,Wetzlar, Germany).
Immunoprecipitation
SK-LMS-1,SK-UT-1B and DMR cells (after 20 h of
serum deprivation) were treated with porcine insulin
10–7 M (Sigma) for 1, 2, 5, or 10 min at 37°C and
subsequently  lysed  at  4°C  in  1  ml  of  solution
containing 50 mM  Tris-HCl,pH 7.0,150 mM NaCl,
5 mM EDTA, 1 mM NaF, 2 mM NaVO4 , 1% (w/v)
Triton  X-100, 100  m g/ml  phenylmethylsulfonyl 
￿ uoride (PMSF), 0.5% (w/v) sodium deoxycholate,
0.1%  (w/v)  SDS, 1  m g/ml  leupeptin, 1  m g/ml 
aprotinin, 1  m g/ml  pepstatin  (RIPA  lysis  buffer).
Cell lysates were clari￿ ed by centrifugation at 13,000
rpm for 20 min at 4°C, and the supernatants were
transferred  to  a  fresh  tube. After  protein  content
determination using the DC Protein Assay (Biorad,
Hercules, CA, USA) and BSA as the standard, equal
amounts of  protein were immunoprecipitated with
the corresponding antibodies at 4°C for 16 h, and 
the  immune complexes  were  collected  on  Protein 
A-Sepharose (Amersham-Pharmacia Biotech, Little
Chalfont,UK) and resolved on a reduced 10% SDS-
PAGE. Cell  lysates  were  precleared  with  protein 
A-Sepharose to minimize non-speci￿ c binding.As an
additional control for non-speci￿ c binding, samples
were  also  immunoprecipitated  with  pre-immune
rabbit or mouse IgG.
Immunoblotting
Cell  lysates  or  immunoprecipitated  proteins  were
resolved on SDS-PAGE and transferred to a nitro-
cellulose ￿ lter. Before immunoblotting, non-speci￿ c
attachment to membranes was blocked using 0.1%
Tween-20  and  0.5%  BSA  in  PBS  for  1  h; the
membranes were then incubated overnight with the
indicated antibodies in 20  mM Tris-HCl, pH 7.4,
150 mM NaCl, and 0.1% Tween-20 (TBS). Blots
were  incubated  with  HRP-conjugated  goat  anti-
rabbit or goat anti-mouse antibodies (1:1000)  and
developed  using  the  ECL  system  (Amersham-
Pharmacia Biotech) and only the relevant part of the
gel is shown.
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Eight-  to  12-week-old  athymic  nude  mice  were
purchased from  Charles River  Italia  (Calco, Italy)
and housed in laminar ￿ ow hoods in sterile cages
with  ￿ lters. Sterile  water  and  rodent  chow  were
provided ad libitum. Cells (6.0 ´ 105) in 0.2 ml 0.9%
NaCl were inoculated s.c.into the interscapular area.
Tumour  incidence, latency  and  growth  rate  were
determined twice  a  week; tumour  diameters  were
measured with  a  caliper  and  the  volume  (V)  was
calculated  according  to  the  formula: V = 1/2LW 2
(where L = length, W = width).
Results
Invasive capacity in Matrigel and tumorigenesis of
leiomyosarcoma cell lines
To  investigate  the  invasive  potential  of  the  SK-
LMS-1, SK-UT-1B, and  DMR  cell  lines, a  semi-
quantitative  in vitro assay was ￿ rst applied. In this
case 5.0 ´ 103 cells were mixed with Matrigel and 
the  gelly￿ ed  matrix  was  incubated  at  37°C  in
DMEM containing 10% FCS.While SK-UT-1B cells
migrated extensively from the gel after 20 h of incu-
bation, only  a  few  SK-LMS-1  cells  were  present
outside  the  gel  and  DMR  did  not  egress  at  all 
(Fig. 1A  and  data  not  shown). Next, to  have  a
measure of their real oncogenic capacity in vivo the
ability to form tumours in nude mice was then inves-
tigated. Also in this  case  a  striking  difference was
noted among the different cell lines: both DMR and
SK-UT-1B  displayed  a  consistent  ability  to  form
solid tumours already at 10 days, that grew to very
large sizes. DMR tumours had a doubling time of
about 5 days between 20 and 30 days post-injection,
whereas  the  exponential  growth  of  SK-UT-1B
tumours  was  delayed  until  day  35  and  then  the
tumours started growing also with a doubling time of
5 days (Fig. 1B). No tumours were detected in mice
injected with SK-LMS-1 cells.
Colonies in agar
To investigate whether the lack of tumorigenesis of
SK-LMS-1 cells might be the consequence of an in
vivo  host  effect, the  ability  to  proliferate  in  an
anchorage-independent  environment  was  then
assayed in vitro in semi-solid agar. Also in this case
both  DMR and SK-UT-1B  cells formed a  similar
number  of  colonies  (Fig. 1C)  with  a  mean  cell
number >30 cells per colony.Although it is generally
accepted that DNA synthesis and cellular prolifera-
tion  can  be  stimulated  very  effectively  by  IGFs,
insulin and its receptor(s) can also stimulate growth
and  metabolism  in  tumour  cells. To  determine
whether the growth in agar of SK-LMS-1 could be
stimulated by supplementation with insulin, colony
formation  was  investigated  in  the  presence  of  a 
physiological dose (10–7 M) of insulin. No substan-
tial  differences  compared  to  cells  grown  in  the
absence of the stimulus were detected when DMR or
SK-UT-1B cells were investigated. Similarly, supple-
mentation  with  insulin  did  not  increase  colony
formation, neither the numbers nor the sizes of the
colonies, also when SK-LMS-1 were stimulated with
insulin (data not shown).
Differential expression and activation of IRS-1 
and IRS-2 
To rule out the possibility that SK-LMS-1 cells had
totally lost sensitivity to insulin, the basal expression
of  IRS-1  and  IRS-2, the  major  substrates  of  the
insulin  receptor, was  ￿ rst  investigated  by
immunoblotting  with  speci￿ c  antibodies  in  cell
lysates.SK-LMS-1 cells expressed high levels of IRS-
1, whereas in both DMR and SK-UT-1B cells IRS-1
was  barely  visible  (Fig. 2). Conversely, very  little 
IRS-2 was present in SK-LMS-1 while DMR and
SK-UT-1B were highly positive for IRS-2. Next, the
insulin-dependent activation was measured at differ-
ent  time  intervals  after  insulin  stimulation  by
immunoblotting with anti-phosphotyrosine antibod-
ies on cell lysates (Fig. 3A).The lowest effective dose
of insulin for the present cell lines has been prelimi-
narly determined based on cell duplication rate to be
around 10–7 M. A transient increase in phosphoryla-
tion was evident between 1 and 5 min post-activation
for bands in the range of 160–180 kDa, compatible
with the migration of IRS-1 and IRS-2.To con￿ rm
that the bands identi￿ ed corresponded to authentic
IRS-1 and IRS-2,cell lysates from each cell line were
￿ rst  immunoprecipitated with either anti-IRS-1 or
IRS-2 antibodies and then the blotted immunopre-
cipitates were probed with anti-phosphotyrosine anti-
bodies  (Fig. 3B). Consistent  with  the  results  of
immunoblotting on total cell extracts (Fig. 2), only
IRS-1  was  immunoprecipitated  from  SK-LMS-1
cells that was not phosphorylated in the absence of
insulin  treatment. After  1  min  treatment, a  rapid
increase  of  IRS-1  phosphorylation  was  detected;
conversely, no activity was detected when the SK-
LMS-1 cell lysate was immunoprecipitated with anti
IRS-2 antibodies and probed with anti-phosphotyro-
sine antibodies (data not shown). Insulin-dependent
IRS-2 activation was detected instead in both DMR
and SK-UT-1B  cell lysates at  1 min. At 2  min of
insulin  stimulation, phosphorylation  had  declined
signi￿ cantly in SK-UT-1B, whereas it remained con-
stant in DMR and even increased in SK-LMS-1.
Downstream signaling
From  the  preceding  series  of  experiments, it  was 
clear that  the  most  oncogenic cell  lines  expressed
exclusively  IRS-2, whereas  the  non-tumourigenic
SK-LMS-1 cells expressed only IRS-1.Furthermore,
upon  insulin  stimulation  the  respective  principal
1
1
1
IRSs downstream signaling and leiomyosarcoma 9192 Colombatti et al.
Fig. 1. Invasive and growth capacity in vitro and tumour development in vivo. (A) Matrigel invasion. Cells were included in cold
Matrigel, plated, incubated for 20 h at 37°C and then photographed under phase contrast.The dotted line indicates the hedge of the
Matrigel drop. (B) Tumour development in nude mice. Mice were injected in the interscapular area with 6.0 ´ 105 cells of the indi-
cated cell lines and tumour mass measured at different time intervals.(C) Anchorage-independent growth.A total of 3.75 x 104 cells/well
was seeded in semisolid agar plates in complete medium and colony formation was evaluated under phase contrast at 5 (A,C,D) and
10 (B) days. (A,B) SK-LMS-1; (C) SK-UT-1B; and (C) DMR.substrate  of  the  insulin  receptor  tyrosine  kinase
expressed  within  a  given  cell  was  activated. This
raised the question as to whether the downstream
signaling cascade would be different depending upon
which IRS was expressed and activated. Thus, the
role of PI3-kinase, a central molecule in the insulin
signaling was ￿ rst analysed. Cell lysates of insulin-
stimulated  SK-LMS-1, and  SK-UT-1B  or  DMR
were immunoprecipitated with anti-IRS-1 or -IRS-2
antibodies, respectively, and the blotted precipitates
were probed with anti-PI3-kinase antibody. Already
at 1 min a strong association was detected in all cell
samples that increased slightly at 2 min (Fig. 4A).
Thus, no  difference  between  IRS-1  and  IRS-2
expressing cells was apparent in PI3-kinase associa-
tion.
Next, the Ras/MAPK pathway that is known to be
involved in determining cell proliferation and loco-
motion in several tumour systems21 was analysed. In
fact, this pathway might have been differently acti-
vated  in the  less malignant  SK-LMS-1  versus the
more  malignant  SK-UT-1B  and  DMR  cells.
However, after repeated attempts to demonstrate a
direct association between IRS-1 or IRS-2 and Grb2
as a way to activate the Ras pathway, no association
was detected notwithstanding a strong expression of
Grb2 in all cell lines (data not shown). Another way
in which the Ras/MAPK pathway could be differently
activated  between  SK-LMS-1  and  SK-UT-1B  or
DMR cells is via association of Shc with Grb2. An
increase in the phosphorylation of the 52-kDa species
of Shc was evident at 2 min and remained constant
at 5 min in SK-LMS-1 and SK-UT-1B cells,whereas
in DMR the phosphorylation peaked at 5 min and
then returned at normal levels at 10 min (Fig. 4B).
The association with Grb2 was demonstrable for all
three cell lines starting at 2 min; then, it remained
constant  up  to  5  min  in  SK-LMS-1, whereas  it
peaked at 5 min in SK-UT-1B and DMR (Fig. 4B).
Discussion
IRS-1 and IRS-2 represent the most upstream mole-
cules in the signal transduction cascade mediated by
insulin  and  other  ligands. Several  intermediate
signaling  events  including  the  activation  of  PI3-
kinase pathway,22 have  been implicated in insulin-
and IGF-1-stimulated  mitogenesis. However, IRSs
are essential not only for insulin-induced mitogenic
effects but may even contribute to epithelial carcino-
genesis.23–25 Therefore, notwithstanding  the  legiti-
mate  concern  that  the  connection  between  the
differential expression of IRS-1 and IRS-2 events and
events that materialize days (colonies in agar) or even
weeks (tumours) later, we tested the hypothesis that
constitutive high expression of these molecules may
result in a more malignant and tumourigenic pheno-
type  also  in  leiomyosarcomas; in  addition, it  was
analysed  whether  IRS  genes  activation  triggers
different downstream cascades that might be associ-
ated with a differential malignant behaviour.
At least two lines of evidence led us to suggest that
IRS-2 could contribute to enhanced malignancy in
uterine leiomyosarcoma cell lines. First, IRS-2 was
expressed in  SK-UT-1B  and  DMR  cell  lines  that
displayed strong anchorage-independent growth  in
agar and were tumourigenic in vivo, whereas IRS-1
was expressed in the non-tumourigenic SK-LMS-1
cell  line. In  addition, SK-LMS-1  did  not  form
colonies in agar, nor were these cells able to egress
out of Matrigel, whereas both SK-UT-1B and DMR
cells formed large colonies in agar, and SK-UT-1B
migrated extensively out of Matrigel indicating that
malignant characteristics other than in vivo tumori-
genesis were associated with IRS-2-expressing cells.
The ￿ nding that DMR cells did not migrate out of
Matrigel might depend on the lack of expression of
the appropriate integrins (P. Spessotto et al., unpub-
lished data). Second, in both SK-UT-1B and DMR
cell lines insulin enhanced tyrosine phosphorylation
of  IRS-2  and  IRS-2-associated  PI3-kinase. Since
preliminary insulin dose-response relationship exper-
iments  had  indicated  that  the  present  cell  lines
responded  by  an  increased  proliferation  at  doses
around or higher than 10–7 M, we have not further
investigated whether lower concentrations might still
trigger any signaling molecule.
Thus, insulin at 10-7 M similarly stimulated tyro-
sine phosphorylation of IRS-1 and IRS-1-associated
PI3-kinase  in  SK-LMS-1  cells, indicating  that 
the  major  key  downstream  signaling  switch22 was 
not  differentially  activated  in  IRS-1-  and  IRS-2-
expressing  smooth  muscle  cell  tumours. Further-
more,also the Ras/MAPK pathway did not seem one
of  the  major  direct  targets  of  insulin  stimulation 
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Fig. 2. Basal expression of  IRS-1 and  IRS-2. SK-LMS-1
(a), SK-UT-1B  (b), DMR  (c), and  mammary  carcinoma
MDA (d)  cells were lysed in  RIPA  lysis  buffer, clari￿ ed  by
centrifugation  and  equal  amounts  of  proteins  (75  m g)  were
resolved  by  SDS-PAGE  and  immunoblotted  with  antisera
speci￿ c for IRS-1 and IRS-2.The ￿ lter was incubated ￿ rst with
IRS-1 antibody, stripped and then incubated with the IRS-2
antibody. Exposure  times  were  the  same. Only  the  relevant 
part of the blot is shown. IB, immunoblotting; MW , molecular
weight (´10–3).94 Colombatti et al.
Fig. 3. Effects of insulin treatment on the phosphorylation of IRS-1 and IRS-2. Exponentially growing cells were seeded in serum-
free medium for 24 h before stimulation with insulin (0.1 m M) for various lengths of time (0–10 min). (A) Immunoblotting of cell
lysates. Cells were lysed in RIPA lysis buffer, clari￿ ed by centrifugation and equal amounts of proteins (75 m g) were resolved by 10%
SDS-PAGE and immunoblotted with antibody PY20 speci￿ c for phosphotyrosine.The PY20 antibody labels bands in the range of
160–180 kDa corresponding to IRS-1 and IRS-2. (B) Immunoprecipitation and immunoblotting. Clari￿ ed cell lysates (1 mg of
protein) were immunoprecipitated overnigth with either IRS-1 or IRS-2 antibodies and then the washed pellets were resolved by 10%
SDS-PAGE and immunoblotted with IRS-1,IRS-2,and PY20 antibodies.Only the relevant part of the blot is shown.(C) Epidermoid
carcinoma A431 cells stimulated with 0.1 m M insuline for 1.5 min; IB, immunoblotting; IP, immunoprecipitation; MW , molecular
weight (´10–3).in either IRS-1- or IRS-2-positive leiomyosarcomas.
In this case, the explanation for the lack of correla-
tion could be that the role played by IRSs in MAP
kinase activation differs from tissue to tissue26 and
this type of tumours belong to a tissue histotype that
is not particularly active in this respect.
Finally,the downstream signaling following insulin-
dependent IRS activation demonstrated that Shc was
activated and associated with Grb2 in both IRS-1 and
IRS-2 expressing cell lines.Thus, the ￿ nding that the
major transformation-related signaling pathways acti-
vated by IRS-1 and IRS-2 resulted in being highly 
similar if not identical makes it unlikely that the dif-
ferent biological behaviours of the uterine leiomyosar-
comas  examined  in  the  present  study  are  directly
linked to the insulin pathway, as shown in other types
of tumours.24,27–29The minor differences in the dura-
tion and/or in the timing of peak activities (phospho-
rylation and/or association between Shc and Grb2)
detected  do  not  seem  to  be  relevant  in  view 
of the fact that they were not speci￿ cally related to
either IRS-1 or IRS-2 expression.Whether differences
between IRS-1- and/or IRS-2-expressing cells in PI3-
kinase-dependent pathways not examined here might
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Fig. 4. Insulin-dependent signaling in uterine leiomyosarcoma cell lines.(A) Association of PI 3-kinase with IRS-1 and IRS-2.(B)
Activation of Shc and association between Shc and Grab2. Exponentially growing cells were seeded in serum-free medium for 24 h
before stimulation with insulin (0.1 m M) for various lengths of time (0–2 min or 0–10 min). Clari￿ ed lysates (1 mg of protein) were
immunoprecipitated overnigth with either IRS-1 or IRS-2 or with Shc antibodies and then the washed pellets were resolved by 10%
SDS-PAGE and immunoblotted with PI 3-kinase antibody (A) or with PY20 anti-phosphotyrosine,stripped and reprobed with Grb2
antibodies (B). Only the relevant part of the blot is shown. IB, immunoblotting, IP , immunoprecipitation.96 Colombatti et al.
be  responsible  for  the  distinct  phenotypes  of
leiomyosarcomas is a matter of further investigation.
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